| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |